JAK2 as Predictor of Therapeutic Response in Patients with Chronic Myeloid Leukemia Treated with Imatinib
Table 4
Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and area under the receiver operating characteristic (ROC) curve (AUC) of the presence of complete hematological response and early molecular response using cutoff values of baseline JAK2 levels (before imatinib treatment).